uniQure Investors Eligible to Lead Securities Fraud Lawsuit

The Schall Law Firm reminds investors of a class action lawsuit against uniQure N.V. for violations of securities laws.

Published on Feb. 13, 2026

Got story updates? Submit your updates here. ›

The Schall Law Firm, a national shareholder rights litigation firm, has reminded investors of a class action lawsuit against uniQure N.V. (NASDAQ: QURE) for violations of securities laws. Investors who purchased the company's securities between September 24, 2025, and October 31, 2025, are encouraged to contact the firm before April 13, 2026, to participate in the lawsuit.

Why it matters

This lawsuit highlights the importance of transparency and accurate disclosures in the securities market. Investors rely on companies to provide truthful information, and any misleading statements can lead to significant financial losses.

The details

According to the complaint, uniQure failed to secure full FDA approval for its Pivotal Study and misled the market about the chances it would have to delay its BLA timeline to supplement the data it submitted to the FDA. The company's public statements were allegedly false and materially misleading throughout the class period, leading to investor losses when the truth was revealed.

  • The class period is from September 24, 2025, to October 31, 2025, inclusive.
  • Investors have until April 13, 2026, to contact the Schall Law Firm to participate in the lawsuit.

The players

uniQure N.V.

A biopharmaceutical company that develops gene therapies for rare genetic disorders.

The Schall Law Firm

A national shareholder rights litigation firm that specializes in securities class action lawsuits and shareholder rights litigation.

Got photos? Submit your photos here. ›

What they’re saying

“We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.”

— Brian Schall, Attorney, The Schall Law Firm (The Schall Law Firm)

What’s next

The judge will decide on April 13, 2026, whether to certify the class in this lawsuit.

The takeaway

This case highlights the importance of accurate and transparent disclosures by public companies. Investors who suffered losses due to uniQure's alleged misleading statements may have the opportunity to recover their losses through this class action lawsuit.